Ketamine, a drug approved for use as a general anesthetic and sedative, also appears to provide significant relief to patients with major depressive disorder, and those with chronic post-traumatic stress disorder (PTSD), according to two separate studies conducted by researchers at Icahn School of Medicine at Mount Sinai.
After launching a much-publicized campaign in October to promote the influenza vaccination for faculty, staff, and students, the Mount Sinai Health System will report a record rate of vaccination compliance to the New York State Department of Health (NYSDOH) for the 2013 – 2014 influenza season.
Typically, vaccination rates for health care workers are around 60 percent, according to the U.S. Centers for Disease Control and Prevention. The Health System’s overall compliance rate was 82 percent at the start of April.
Two newly identified proteins that appear to play a critical role in the development of aggressive triple-negative breast cancer (TNBC) could also lead to potential new treatments, according to scientists at Icahn School of Medicine at Mount Sinai, the University of Kentucky, MD Anderson Cancer Center, and several medical centers in China.
On January 12th, 2010 when a catastrophic magnitude 7.0 earthquake hit Haiti, Ernest Barthelemy was half way through his second of medical school at the Icahn School of Medicine at Mount Sinai. The earthquake that devastated Haiti hit Ernest in every way, from the personal casualties within his family to its spiritual implications for his cultural identity to an eventual redefinition of his professional medical career.
One hundred twenty-seven members of Icahn School of Medicine at Mount Sinai’s Class of 2014 participated in the nation’s annual Match Day event on Friday, March 21. They gathered in the Annenberg West lobby to open their envelopes en masse and find out which residency programs they would be attending during the next phase of their training.
Icahn School of Medicine at Mount Sinai and The New York Academy of Medicine (NYAM) announced the formation of a new partnership to jointly study and address a number of significant health issues and policies that impact the lives of people who live in urban areas. NYAM is an historic and independent institution that has been advancing the health of people living in cities since its founding in 1847.
Mitral Valve Prolapse (MVP) is a common heart valve abnormality that affects up to 5 percent of the U.S. population. The mitral valve controls the flow of blood from the lungs to the main pumping chamber of the heart. MVP results from a degeneration of valve structure that leads to a regurgitation of blood backwards that can result in heart enlargement and weakening, as well as fatigue and shortness of breath.
The Icahn School of Medicine at Mount Sinai, and National Jewish Health, the nation’s leading respiratory hospital, based in Denver, Colorado, have created a partnership to advance patient care and research in respiratory and related diseases. The Mount Sinai–National Jewish Health Respiratory Institute is expected to open on the Icahn School of Medicine campus in July.
The Mount Sinai Health System recently established the Mount Sinai Institute of Technology (MSIT), with a $5 million grant from the New York City Economic Development Corporation (NYCEDC). As part of Icahn School of Medicine at Mount Sinai, MSIT will train students to develop technology-based solutions that improve human health, and serve as an incubator for transformative, cost-effective discoveries.